Home » Topics » BioWorld Science

BioWorld Science
RSS

METTL3 inhibition with STM-2457 leads to antitumor effects in OSCC

March 8, 2022

LABP-73 demonstrates efficacy in preclinical models of chronic asthma

March 8, 2022

BMAL1 disruption has an impact on metabolic and liver disease

March 8, 2022

Nanoengineered Bifidobacterium bifidum suppresses tumors in vivo

March 8, 2022

VYN-201 reduces key inflammatory biomarkers involved in vitiligo pathogenesis in preclinical model

March 7, 2022

Modulation of RICTOR/mTORC2 axis is an approach for sensorineural hearing loss

March 7, 2022

Regulation of BIN1 ameliorates dynamin-related myopathy

March 7, 2022

Novel UV-mediated antigen-presenting nanoparticles for mRNA delivery to virus-specific T cells

March 7, 2022

PEAK3 promotes cell proliferation and migration in vitro

March 7, 2022

Novartis discloses EZH2 and EED inhibitors

March 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...